• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

COX:FP

2.1510 EUR 0.0350 1.60%

As of 11:35:00 ET on 09/23/2014.

Snapshot for NicOx SA (COX)

Open: 2.1800 Day's Range: 2.1430 - 2.1800 Volume: 204,122
Previous Close: 2.1860 52wk Range: 1.7050 - 2.9280 1-Yr Rtn: -20.19%

Stock Chart for COX

No chart data available.
  • COX:FP 2.1510
  • 1D
  • 1M
  • 1Y
2.1860
Interactive COX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for COX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -0.2651
Est. EPS (EUR) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 161.62
Shares Outstanding (M) 75.14
30 Day Average Volume 392,018
Price/Book (mrq) 2.5315
Price/Sale (ttm) 524.5213
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date 05/30/1999
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for COX

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for COX

NicOx develops pharmaceuticals using recently discovered properties of nitric oxide. The Company develops drugs-candidates for the potential treatment of inflammatory, cardiometabolic and ophthalmological diseases. NicOx's lead compound naproxcinod is developed for the relief of the signs and symptoms of osteoarthritis.

Michele GarufiChairman/CEO/Co-FounderEvelyne NguyenChief Financial Officer
Philippe MasquidaExec VP/Mng Dir:European & Intl OpsGavin SpencerExec VP:Corporate Development
More Company Profile & Key Executives for COX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil